Systemic microvascular rarefaction is correlated with dysfunction of late endothelial progenitor cells in mild hypertension: a substudy of EXCAVATION-CHN1

Jianwen Liang, Yan Li, Long Chen, Wenhao Xia, Guifu Wu, Xinzhu Tong, Chen Su, Jiang He, Xiufang Lin, Jun Tao, Jianwen Liang, Yan Li, Long Chen, Wenhao Xia, Guifu Wu, Xinzhu Tong, Chen Su, Jiang He, Xiufang Lin, Jun Tao

Abstract

Background: Hypertension often presents with microvascular rarefaction (MVR), which is closely associated with impaired angiogenesis. Early detection of MVR is essential for systemic assessment in patient with hypertension. We aimed to determine the systemic MVR through both optical coherence tomography angiography (OCTA) and intravital capillaroscopy, and to investigate their respective efficacies and related mechanisms associated with late endothelial progenitor cells (LEPCs) dysfunction.

Methods: Seventy-one hypertensive and sixty-nine age-match normotensive subjects were included in this study. All subjects received intravital capillaroscopy for skin capillary density (SCD) and OCTA for retinal capillary density (RCD) and non-perfused areas (R-NPA). Subsequently, correlation of LEPCs activities and microvascular rarefaction were examined.

Results: Compared with normotensive subjects, hypertensive patients had significantly lower RCD [(52.9 ± 2.9)% vs. (57.8 ± 1.6)%, P < 0.01] and higher R-NPA [(0.12 ± 0.07) mm2 vs. (0.053 ± 0.020) mm2, P < 0.01]. SCD correlated positively with RCD but negatively with R-NPA [(RCD: OR = 0.40, 95% CI 0.25-0.67, P < 0.01); (R-NPA: OR = 0.39, 95% CI - 0.0029 to 0.0011, P < 0.01)]. The discriminative powers of RCD performed best (AUC 0.79 versus SCD AUC 0.59, P < 0.001) followed by R-NPA (AUC 0.73 versus SCD AUC 0.59, P < 0.001) for systolic blood pressure. Similar pattern is also found for diastolic blood pressure (RCD AUC 0.80 versus SCD AUC 0.54, P < 0.001; R-NPA AUC 0.77 versus SCD AUC 0.54, P < 0.001). Furthermore, LEPCs tube formation was impaired in hypertensive patients (36.8 ± 2.3 vs. 28 ± 3.7, P < 0.01). After multivariate adjustments, positive correlation existed between RCD or R-NPA with LEPCs tube formation (RCD: β = 0.64, 95% CI 0.34-0.91, P < 0.01; R-NPA: β = - 24.67, 95% CI - 43.14 to - 4.63, P < 0.05) but not with SCD (β = 0.082, 95% CI 0.01-0.18, P = 0.085).

Conclusion: Compared to intravital capillaroscopy, OCTA is a more precise technique for early detection of hypertensive microvascular rarefaction, which is associated with the fall in LEPC-mediated angiogenesis. Both of OCTA and LEPCs function can help identify hypertension-related capillary abnormality. Trail Registration The trial is a substudy of EXCAVATION-CHN1, registered at clinicaltrials.gov as NCT02817204 (June 26, 2016).

Keywords: Hypertension; Late endothelial progenitor cells; Microcirculation; Microvascular rarefaction; Optical coherence tomography angiography.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Quantification and representative photographs of SCD, RCD, R-NPA in normotension and hypertension. A Quantification of SCD at rest and after 2-min VC in both groups; B representative photographs of SCD at rest and after VC in both groups. Hypertensive SCD (b, d) was reduced than the normotensive (a, c) in the rest state and after 2-min VC; C quantification of RCD in both groups; D representative photographs of retinal vessel map and flow density map. Both hypertensive retinal vessel map (b) and flow density map (d) decreased than that in normotension (a, c); E quantification of R-NPA in both groups; F Representative photographs of R-NPA. Yellow zone represented non-perfused areas. Representative photographs of retinal NPA in hypertension (b) increased than that in normotension (a). (B 0.66 mm2 per field, magnification 136, scale bar 100 μm; D and F optical axial resolution, 5 microns; optical transverse resolution, 15 microns). VC venous congestion, RCD retina capillary density, R-NPA retinal non-perfused areas
Fig. 2
Fig. 2
Correlation and receiver operating characteristic (ROC) analysis about results of intravital capillaroscopy and OCTA. A Scatter plots of correlation between RCD and SCD (a) and scatter plots of correlation between R-NPA and SCD (b). B ROC curve for SCD and RCD, R-NPA. ROC was performed for blood pressure (definition of high blood pressure), n = 140. a with SBP analysis, AUC for SCD is 0.68, 0.72 for RCD and 0.79 for R-NPA; b with DBP analysis, AUC for SCD is 0.64, 0.81 for RCD and 0.78 for R-NPA. OCTA optical coherence tomography angiography, SCD skin capillary density, RCD retina capillary density, R-NPA retina non-perfused areas, AUC area under the curve
Fig. 3
Fig. 3
Effects of hypertension on LEPCs functions. A Quantification of migration, adhesion and tube formation ability of LEPCs. LEPCs functions decreased in hypertension (P < 0.01 vs. normotension); B representative photographs of LEPCs functions. a, b Representative photographs of LEPCs migration; c, d representative photographs of LEPCs adhesion; e, f representative photographs of LEPCs tube formation (magnification 100, scale bar 100 μm). Number of per hp for migration and adhesion, number of per mm2 for tube. LEPCs late endothelial cells
Fig. 4
Fig. 4
Correlation analysis of SCD, RCD/R-NPA and LEPCs tube formation. a Scatter plots of correlation between SCD and LEPCs tube formation; b scatter plots of correlation between RCD and LEPCs tube formation; c scatter plots of correlation between R-NPA and LEPCs tube formation. SCD skin capillary density, RCD retina capillary density, R-NPA retina non-perfused areas, LEPCs late endothelial cells

References

    1. Forouzanfar PH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mmHg, 1990–2015. JAMA. 2017;317(2):165–182. doi: 10.1001/jama.2016.19043.
    1. Rapsomaniki E, Timmis A, George J, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet. 2014;383(9932):1899–1911. doi: 10.1016/S0140-6736(14)60685-1.
    1. Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation. 2001;104(6):735–740. doi: 10.1161/hc3101.091158.
    1. He FJ, Marciniak M, Markandu ND, Antonios TF, MacGregor GA. Effect of modest salt reduction on skin capillary rarefaction in white, black, and Asian individuals with mild hypertension. Hypertension. 2010;56(2):253–259. doi: 10.1161/HYPERTENSIONAHA.110.155747.
    1. Triantafyllou A, Anyfanti P, Pyrpasopoulou A, Triantafyllou G, Aslanidis S, Douma S. Capillary rarefaction as an index for the microvascular assessment of hypertensive patients. Curr Hypertens Rep. 2015;17(5):33. doi: 10.1007/s11906-015-0543-3.
    1. Noon JP, Walker BR, Webb DJ, et al. Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure. J Clin Invest. 1997;99(8):1873–1879. doi: 10.1172/JCI119354.
    1. Sane DC, Anton L, Brosnihan KB. Angiogenic growth factors and hypertension. Angiogenesis. 2004;7(3):193–201. doi: 10.1007/s10456-004-2699-3.
    1. Fernandes T, Nakamuta JS, Magalhães FC, et al. Exercise training restores the endothelial progenitor cells number and function in hypertension: implications for angiogenesis. J Hypertens. 2012;30(11):2133–2243. doi: 10.1097/HJH.0b013e3283588d46.
    1. Minami Y, Nakajima T, Ikutomi M, et al. Angiogenic potential of early and late outgrowth endothelial progenitor cells is dependent on the time of emergence. Int J Cardiol. 2015;186:305–314. doi: 10.1016/j.ijcard.2015.03.166.
    1. Zhang XY, Su C, Cao Z, et al. CXCR10 upregulation is required for early endothelial progenitor cell-mediated endothelial repair in patients with hypertension. Hypertension. 2014;63(2):383–389. doi: 10.1161/HYPERTENSIONAHA.113.02273.
    1. Liu X, Zhang GX, Zhang XY, et al. Lacidipine improves endothelial repair capacity of endothelial progenitor cells from patients with essential hypertension. Int J Cardiol. 2013;168(4):3317–3326. doi: 10.1016/j.ijcard.2013.04.041.
    1. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension. 1999;33(4):998–1001. doi: 10.1161/01.HYP.33.4.998.
    1. Antonios TF, Rattray FE, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Maximization of skin capillaries during intravital video-microscopy in essential hypertension: comparison between venous congestion, reactive hyperaemia and core heat load tests. Clin Sci (Lond) 1999;97(4):523–528. doi: 10.1042/cs0970523.
    1. Bandello F. OCT angiography in retinal and macular diseases. Basel: KARGER; 2016.
    1. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348(7):593–600. doi: 10.1056/NEJMoa022287.
    1. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353(10):999–1007. doi: 10.1056/NEJMoa043814.
    1. Ingram DA, Mead LE, Tanaka H, et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood. 2004;104(9):2752–2760. doi: 10.1182/blood-2004-04-1396.
    1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–e115.
    1. Williams B, Mancia G, Spiering W, et al. 2018 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH) J Hypertens. 2018;36:1953–2041. doi: 10.1097/HJH.0000000000001940.
    1. Xia WH, Chen L, Liang JW, et al. BMP4/Id2 signaling pathway is a novel therapeutic target for late outgrowth endothelial progenitor cell-mediated endothelial injury repair. Int J Cardiol. 2016;228:796–804. doi: 10.1016/j.ijcard.2016.11.027.
    1. Pernerstorfer T, Hollenstein U, Hansen J, et al. Heparin blunts endotoxin-induced coagulation activation. Circulation. 1999;100(25):2485–2490. doi: 10.1161/01.CIR.100.25.2485.
    1. Triantafyllou A, Anyfanti P, Zabulis X, et al. Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients. J Am Soc Hypertens. 2014;8(8):542–549. doi: 10.1016/j.jash.2014.04.008.
    1. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension. 1999;34(4 Pt 1):655–658. doi: 10.1161/01.HYP.34.4.655.
    1. Antonios TF, Rattray FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart. 2003;89(2):175–178. doi: 10.1136/heart.89.2.175.
    1. Wong YT, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351(22):2310–2317. doi: 10.1056/NEJMra032865.
    1. Dimmitt SB, West JN, Eames SM, Gibson JM, Gosling P, Littler WA. Usefulness of ophthalmoscopy in mild to moderate hypertension. Lancet. 1989;1(8647):1103–1106. doi: 10.1016/S0140-6736(89)92384-2.
    1. Yannuzzi LA. Indocyanine green angiography: a perspective on use in the clinical setting. Am J Ophthalmol. 2011;151(5):745–751. doi: 10.1016/j.ajo.2011.01.043.
    1. Kogure K, Choromokos E. Infrared absorption angiography. J Appl Physiol. 1969;26(1):154–157. doi: 10.1152/jappl.1969.26.1.154.
    1. Jia Y, Tan O, Tokayer J, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express. 2012;20(4):4710–4725. doi: 10.1364/OE.20.004710.
    1. Huang D, Jia Y, Gao SS, Lumbroso B, Rispoli M. Optical coherence tomography angiography using the optovue device. Dev Ophthalmol. 2016;56:6–12. doi: 10.1159/000442770.
    1. Wang RK, Ma Z. Real-time flow imaging by removing texture pattern artifacts in spectral-domain optical Doppler tomography. Opt Lett. 2006;31(20):3001–3003. doi: 10.1364/OL.31.003001.
    1. Wang RK, An L. Doppler optical micro-angiography for volumetric imaging of vascular perfusion in vivo. Opt Express. 2009;17(11):8926–8940. doi: 10.1364/OE.17.008926.
    1. Spaide RF, Klancnik JM, Jr, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(1):45–50. doi: 10.1001/jamaophthalmol.2014.3616.
    1. de Carlo TE, Romano A, Waheed NK, Duker JS. A review of optical coherence tomography angiography (OCTA) Int J Retina Vitreous. 2015;1:5. doi: 10.1186/s40942-015-0005-8.
    1. Chen L, Ding ML, Wu F, et al. Impaired endothelial repair capacity of early endothelial progenitor cells in hypertensive patients with primary hyperaldosteronemia: role of 5,6,7,8-tetrahydrobiopterin oxidation and endothelial nitric oxide synthase uncoupling. Hypertension. 2016;67(2):430–439. doi: 10.1161/HYPERTENSIONAHA.115.06597.
    1. Lee WH, Park JH, Won Y, et al. Retinal microvascular change in hypertension as measured by optical coherence tomography angiography. Sci Rep. 2019;9(1):156. doi: 10.1038/s41598-018-36474-1.
    1. Chua J, Chin CWL, Hong J, et al. Impact of hypertension on retinal capillary microvasculature using optical coherence tomographic angiography. J Hypertens. 2019;37(3):572–580. doi: 10.1097/HJH.0000000000001916.
    1. Levy BI, Schiffrin EL, Mourad JJ, et al. Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. Circulation. 2008;118(9):968–976. doi: 10.1161/CIRCULATIONAHA.107.763730.
    1. Tricco AC, Ivers NM, Grimshaw JM, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833):2252–2261. doi: 10.1016/S0140-6736(12)60480-2.
    1. Gepstein R, Rosman Y, Rechtman E, et al. Association of retinal microvascular caliber with blood pressure levels. Blood Press. 2012;21(3):191–196. doi: 10.3109/08037051.2012.645336.
    1. Bock KD. Regression of retinal vascular changes by antihypertensive therapy. Hypertension. 1984;6(6 Pt 2):158–162.

Source: PubMed

3
Subscribe